Portfolio von Stonepine Capital Management, LLC
55 gemeldete Positionen · zum 31.03.2026
Originalmeldung · Zehn größte Positionen: 69.9 % des Aktienteils
Aufteilung nach Branche
- Nicht zugeordnet 100,0 %
Einstufung von Titelia, Gesellschaft für Gesellschaft. Der nicht zugeordnete Anteil bleibt sichtbar.
Aufteilung nach Währung
- USD 100,0 %
Die gemeldete Notierungswährung jeder Position.
Länderaufteilung
- US 97,5 %
- AU 2,5 %
- DK 0,1 %
Anteile berechnet auf den Aktienteil.
| Rang | Land | Positionen | Wert | Anteil |
|---|---|---|---|---|
| 1 | US | 53 | 102,1 Mio. $ | 97,48 % |
| 2 | AU | 1 | 2,6 Mio. $ | 2,45 % |
| 3 | DK | 1 | 73.332 $ | 0,07 % |
Positionen
| Rang | Gesellschaft | Stücke | Wert | Gewicht |
|---|---|---|---|---|
| 1 | Verastem Inc | 3.302.300 | 17,5 Mio. $ | |
| 2 | Tenax Therapeutics Inc | 975.200 | 15,6 Mio. $ | |
| 3 | Evolus Inc | 1.759.091 | 7,2 Mio. $ | |
| 4 | ADMA Biologics Inc | 740.000 | 6,7 Mio. $ | |
| 5 | CAMP4 THERAPEUTICS CORP | 1.389.622 | 6,1 Mio. $ | |
| 6 | Nektar Therapeutics | 85.000 | 6,1 Mio. $ | |
| 7 | Zevra Therapeutics Inc | 480.000 | 4,5 Mio. $ | |
| 8 | Corbus Pharmaceuticals Holdings Inc | 383.462 | 3,6 Mio. $ | |
| 9 | Abeona Therapeutics Inc | 746.587 | 3,3 Mio. $ | |
| 10 | KAZIA THERAPEUTICS LTD | 345.179 | 2,6 Mio. $ | |
| 11 | AN2 Therapeutics Inc | 713.845 | 2,4 Mio. $ | |
| 12 | XOMA Royalty Corp | 69.500 | 2,2 Mio. $ | |
| 13 | Aytu BioPharma Inc | 792.289 | 2,2 Mio. $ | |
| 14 | CURIS INC | 3.726.406 | 2 Mio. $ | |
| 15 | TELA BIO INC | 2.617.252 | 1,6 Mio. $ | |
| 16 | Inhibikase Therapeutics Inc | 957.202 | 1,6 Mio. $ | |
| 17 | Adicet Bio Inc | 221.955 | 1,5 Mio. $ | |
| 18 | X4 PHARMACEUTICALS INC | 335.309 | 1,4 Mio. $ | |
| 19 | Heron Therapeutics Inc | 1.402.191 | 1,1 Mio. $ | |
| 20 | Pulmonx Corp | 768.288 | 991.092 $ | |
| 21 | IN8BIO INC | 663.412 | 981.850 $ | |
| 22 | Surrozen Inc | 33.005 | 961.436 $ | |
| 23 | CytomX Therapeutics Inc | 200.000 | 940.000 $ | |
| 24 | PMV Pharmaceuticals Inc | 708.102 | 878.046 $ | |
| 25 | BioAge Labs Inc | 50.000 | 874.500 $ | |
| 26 | MaxCyte Inc | 1.004.673 | 705.783 $ | |
| 27 | Codexis Inc | 417.994 | 681.330 $ | |
| 28 | BOUNDLESS BIO INC | 597.682 | 657.450 $ | |
| 29 | Zentalis Pharmaceuticals Inc | 269.100 | 629.694 $ | |
| 30 | PASITHEA THERAPEUTICS CORP | 831.301 | 616.659 $ | |
| 31 | Phathom Pharmaceuticals Inc | 50.010 | 555.611 $ | |
| 32 | OnKure Therapeutics Inc | 132.578 | 548.873 $ | |
| 33 | Xilio Therapeutics Inc | 64.162 | 539.602 $ | |
| 34 | Verrica Pharmaceuticals Inc | 99.735 | 527.598 $ | |
| 35 | Candel Therapeutics Inc | 102.500 | 502.250 $ | |
| 36 | PRECISION OPTICS INC MASS | 100.000 | 439.000 $ | |
| 37 | Upstream Bio Inc | 35.000 | 315.000 $ | |
| 38 | Opus Genetics Inc | 68.688 | 312.530 $ | |
| 39 | Arvinas Inc | 27.500 | 291.500 $ | |
| 40 | Pliant Therapeutics Inc | 224.650 | 283.059 $ | |
| 41 | Janux Therapeutics Inc | 20.000 | 278.000 $ | |
| 42 | OmniAb Inc | 164.045 | 257.551 $ | |
| 43 | Xeris Biopharma Holdings Inc | 40.030 | 232.174 $ | |
| 44 | Neumora Therapeutics Inc | 100.000 | 195.000 $ | |
| 45 | SAB Biotherapeutics Inc | 50.000 | 191.500 $ | |
| 46 | SI-BONE Inc | 14.964 | 188.995 $ | |
| 47 | CNS PHARMACEUTICALS INC | 61.000 | 145.790 $ | |
| 48 | PROCESSA PHARMACEUTICALS INC | 55.000 | 138.875 $ | |
| 49 | Cabaletta Bio Inc | 50.000 | 134.500 $ | |
| 50 | KALARIS THERAPEUTICS INC | 20.400 | 117.708 $ | |
| 51 | Eledon Pharmaceuticals Inc | 35.000 | 107.800 $ | |
| 52 | Ovid therapeutics Inc | 40.000 | 88.800 $ | |
| 53 | EVAXION A/S | 19.713 | 73.332 $ | |
| 54 | MannKind Corp | 16.300 | 39.935 $ | |
| 55 | BIOATLA INC | 65.387 | 10.527 $ |